Information Blocking Rule Update with Waid Ray and Laura Cummins
An episode of the Right Care at Baptist podcast, hosted by BMHCC, titled "Information Blocking Rule Update with Waid Ray and Laura Cummins" was published on February 17, 2021 and runs 30 minutes.
February 17, 2021 ·30m · Right Care at Baptist
Episode Description
Hosts: Henry Sullivant MD, Chief Medical Officer; Jake Lancaster MD, Chief Medical Information Officer Guests: Waid Ray, Associate Chief Legal Council; Laura Cummins, Corporate Privacy and Security Officer Music: Hank Sullivant Learning Objectives: - Learn about the exceptions to the information blocking rule and when they do and don't apply - Understand documentation requirements to justify information blocking - Learn about penalties and plans to enforce the information blocking rule - Learn about at home testing and other changes in testing technique Helpful links: https://www.ama-assn.org/system/files/2021-01/information-blocking-part-1.pdf Annals of Internal Medicine Article ACP 21st Century Cures Act Practice Resources HealthIT.gov Cures Act Final Rule Open Notes and Oncology https://www.healthit.gov/curesrule/resources/information-blocking-faqs Link to CME https://www.surveymonkey.com/r/C55LKSY None of the hosts or guests have financial interests to disclose. CME is available for up to 3 years after the stated release date. Baptist Memorial Health Care Corporation is accredited by the Mississippi State Medical Association to provide continuing medical education for physicians. BMHCC designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. It is the policy of Baptist Memorial Health Care Corporation (BMHCC) to promote balance, independence, objectivity, and scientific rigor in all educational activities; to require disclosure of relevant financial relationships from individuals engaged in content development or planning of a CME activity; to identify and resolve conflicts of interest related to those relationships; and to make disclosure information available to the audience prior to the CME activity. Presenters are required to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations.
Similar Episodes
Apr 12, 2026 ·9m
Apr 8, 2026 ·48m
Apr 5, 2026 ·8m
Mar 29, 2026 ·8m